TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics granted inducement equity awards to nine new employees on October 28, 2026, consisting of options on 71,815 shares and 47,924 RSUs under its Inducement Plan. CFO Fernando Araujo received the largest component: options on 34,419 shares and 22,969 RSUs. Options carry a $66.90 exercise price, equal to the October 28 close, with standard four-year vesting.
Key figures
- Cfo rsus
- 22969
- Cfo options
- 34419
- Rsus granted
- 47924
- Exercise price
- 66.9
- Options granted
- 71815
- Option term years
- 10
- Employees receiving grants
- 9
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.